KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Other Accumulated Expenses (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Other Accumulated Expenses for 17 consecutive years, with $141.7 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 3.74% to $141.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $141.7 million through Dec 2025, down 3.74% year-over-year, with the annual reading at $141.7 million for FY2025, 3.74% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $141.7 million at Bio-Rad Laboratories, up from $127.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $212.7 million in Q2 2022, with the low at $36.0 million in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $155.1 million, with a median of $158.3 million recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses soared 371.51% in 2022, then fell 21.85% in 2023.
  • Over 5 years, Other Accumulated Expenses stood at $36.0 million in 2021, then skyrocketed by 371.51% to $169.6 million in 2022, then decreased by 4.74% to $161.6 million in 2023, then dropped by 8.91% to $147.2 million in 2024, then decreased by 3.74% to $141.7 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $141.7 million, $127.8 million, and $175.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.